Hendel L, Worning H
Dept. of Dermatology, University of Copenhagen, Rigshospitalet, Denmark.
Scand J Gastroenterol. 1989 May;24(4):461-6. doi: 10.3109/00365528909093075.
The exocrine pancreatic function was investigated in 16 patients with progressive systemic sclerosis by means of a meal test (Lundh test) and in 9 of the patients by the secretin-cholecystokinin test as well. Gastrointestinal involvement with progressive systemic sclerosis was evaluated by esophageal manometry and by routine roentgenographic series of the small bowel. Fecal fat excretion measurement, the D-xylose absorption test, and a small-intestinal biopsy procedure were carried out. Duodenal juice was cultured and bacterial counts were estimated. One-third of the patients had reduced exocrine pancreatic function, but only four patients had unequivocally a reduction that could be of clinical importance. The results obtained with the meal test were in accordance with the secretin-cholecystokinin test, indicating a preserved capacity for endogenous stimulation.
通过进餐试验（伦德试验）对16例进行性系统性硬化症患者的胰腺外分泌功能进行了研究，其中9例患者还进行了促胰液素-缩胆囊素试验。通过食管测压和小肠常规X线系列检查评估进行性系统性硬化症患者的胃肠道受累情况。进行了粪便脂肪排泄测量、D-木糖吸收试验和小肠活检。对十二指肠液进行培养并估计细菌计数。三分之一的患者胰腺外分泌功能降低，但只有4例患者的降低具有明确的临床意义。进餐试验的结果与促胰液素-缩胆囊素试验结果一致，表明内源性刺激能力保留。
